# POLYOXYL 35 CASTOR OIL

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2047696
Categories: beauty, cleaning, food, industrial, pharma
Functions: Cleaning agent, Dispersing agent, Emulsifier, Fragrance, Lubricating agent, Processing aids not otherwise specified, Softener and conditioner, Surface modifier, Surfactant (surface active agent), Wetting agent (non-aqueous)
Identifier: DTXSID2047696

> POLYOXYL 35 CASTOR OIL is used as cleaning agent / dispersing agent. EPA CPDat observed this chemical in 33 composition records across product categories including Vehicle, Home maintenance, Cleaning products and household care. Assessed from 26 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 33 composition records across product categories including Vehicle, Home maintenance, Cleaning products and household care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 33 composition records across product categories including Vehicle, Home maintenance, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Cleaning agent, Surfactant (surface active agent), Softener and conditioner.
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 9 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 1750 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 27668 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 350 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 52.75 %w/v
- US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: SOLUTION; Maximum daily exposure: 10588 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 5 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 5 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 1170 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3635 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 0.4 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 5.2 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 1750 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 4 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 1 drug products and 1 package presentations.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as structurallydiverse.

_Assessed by Greenveil._